Physician profile
Alan E Schulman
NPI 1992733034
$103,878.67
in general payments reported to CMS, 2019-2025
85 companies · $7,553 in 2025
The $7,553 reported for 2025 was more than what 88% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $22K · 2021: $19K · 2022: $9,196 · 2023: $12K · 2024: $3,154 · 2025: $7,553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,507 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,188 · Consulting Fee: $5,804 · Travel and Lodging: $770 · Education: $385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,506.86 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,187.50 |
| Consulting Fee | $5,804.00 |
| Travel and Lodging | $769.66 |
| Education | $384.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $33,763.79 | 2019-2025 | |
| Abbvie INC. | $20,999.57 | 2019-2025 | Qulipta, Ubrelvy, Botox |
| Allergan, INC. | $16,940.01 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $14,726.26 | 2019-2025 | Austedo Xr, Austedo Xr |
| Emd Serono, INC. | $2,707.15 | 2019-2025 | Mavenclad |
| Genentech USA, INC. | $2,037.32 | 2019-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Biogen, INC. | $1,332.27 | 2019-2025 | Tysabri, Vumerity, Leqembi |
| Ucb, INC. | $1,005.36 | 2019-2025 | Briviact, Rystiggo, Fintepla |
| Alexion Pharmaceuticals, INC. | $862.40 | 2019-2025 | Ultomiris, Soliris |
| Novartis Pharmaceuticals Corporation | $596.92 | 2019-2025 | |
| Harmony Biosciences LLC | $514.66 | 2020-2025 | Wakix |
| Lundbeck LLC | $427.57 | 2019-2025 | Vyepti, Rexulti |
| Lilly USA, LLC | $395.33 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Sk Life Science, INC. | $344.07 | 2021-2025 | |
| Inspire Medical Systems, INC. | $324.07 | 2022-2023 | Inspire |
Show all 83 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $318.28 | 2020-2025 | |
| Kyowa Kirin, INC. | $289.22 | 2020-2023 | Nourianz |
| Medtronic, INC. | $258.47 | 2022-2023 | Linq II |
| Pfizer INC. | $238.91 | 2019-2025 | |
| Mdd US Operations, LLC | $228.78 | 2019-2024 | Gocovri, Gocovri |
| Astrazeneca Pharmaceuticals Lp | $228.07 | 2021-2024 | Wainua |
| Mallinckrodt Hospital Products INC. | $223.58 | 2020-2024 | Acthar |
| Merz Pharmaceuticals, LLC | $207.90 | 2021-2025 | Xeomin, Inbrija, Ampyra |
| Greenwich Biosciences, INC. | $205.66 | 2019-2021 | |
| Grifols USA, LLC | $192.11 | 2019-2025 | Gamunex-C |
| Alnylam Pharmaceuticals INC. | $191.84 | 2021-2025 | Onpattro |
| Sunovion Pharmaceuticals INC. | $188.68 | 2019-2022 | |
| Acadia Pharmaceuticals INC | $183.78 | 2019-2025 | Nuplazid |
| Neurocrine Biosciences, INC. | $182.49 | 2019-2025 | Ingrezza, Ongentys |
| Acorda Therapeutics, INC | $174.23 | 2019-2024 | Inbrija, Ampyra |
| Biohaven Pharmaceuticals, INC. | $173.44 | 2021 | |
| Neurelis, INC. | $172.02 | 2021-2025 | Valtoco |
| Amgen INC. | $170.35 | 2019-2025 | Uplizna, Aimovig |
| Amneal Pharmaceuticals LLC | $167.48 | 2019-2024 | Rytary, Ongentys 50mg Capsules 30, Crexont |
| Abbott Laboratories | $163.82 | 2019-2025 | Jot Dx |
| Jazz Pharmaceuticals INC. | $163.16 | 2021-2024 | Epidiolex, Xywav |
| Celgene Corporation | $158.99 | 2021-2025 | Zeposia |
| Banner Life Sciences, LLC | $157.54 | 2021-2024 | |
| Argenx US, INC. | $131.11 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Csl Behring | $129.86 | 2019-2024 | Hizentra |
| Ani Pharmaceuticals, INC. | $129.13 | 2022-2025 | Purified Cortrophin Gel |
| E.R. Squibb & Sons, L.L.C. | $124.74 | 2025 | Zeposia |
| Tg Therapeutics, INC. | $122.61 | 2024-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $94.63 | 2024-2025 | Lumryz |
| Janssen Biotech, INC. | $92.59 | 2025 | |
| Avanir Pharmaceuticals, INC. | $91.68 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $91.47 | 2023-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $86.88 | 2021-2022 | |
| Axsome Therapeutics, INC. | $68.51 | 2023-2025 | Symbravo, Sunosi |
| Biohaven Pharmaceutical Holding Company Ltd. | $63.80 | 2022 | |
| Supernus Pharmaceuticals, INC. | $62.80 | 2021-2025 | Qelbree |
| Livanova USA, INC. | $62.34 | 2023-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Catalyst Pharmaceuticals, INC. | $55.65 | 2023-2024 | Fycompa, Firdapse |
| Adamas Pharmaceuticals, INC. | $54.77 | 2019-2020 | |
| Boston Scientific Corporation | $53.73 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $53.36 | 2019 | |
| Life Molecular Imaging Ltd | $48.45 | 2025 | Neuraceq |
| Ipsen Biopharmaceuticals, INC | $45.38 | 2019-2020 | |
| Upsher-Smith Laboratories LLC | $39.64 | 2022 | |
| Revance Therapeutics, INC. | $39.04 | 2024 | Daxxify |
| Ultragenyx Pharmaceutical INC. | $38.46 | 2022-2025 | Dojolvi |
| Collegium Pharmaceutical, INC. | $37.74 | 2022 | |
| Corium, LLC | $33.59 | 2023 | Adlarity |
| Horizon Therapeutics Plc | $31.05 | 2022 | |
| Immedica Pharma US, INC. | $26.65 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $25.84 | 2025 | Arctic Sun 5000 |
| Springworks Therapeutics, INC. | $25.83 | 2025 | Gomekli |
| Merz North America, INC. | $25.20 | 2019 | |
| Sumitomo Pharma America, INC. | $24.91 | 2023-2024 | Aptiom |
| Vanda Pharmaceuticals INC. | $23.39 | 2024 | Ponvory |
| Currax Pharmaceuticals LLC | $23.01 | 2021-2022 | |
| Nevro Corp. | $22.18 | 2019 | |
| Aquestive Therapeutics, INC. | $21.35 | 2019 | |
| Promius Pharma LLC | $21.33 | 2019 | |
| Akcea Therapeutics, INC. | $21.11 | 2019 | |
| Bausch Health US, LLC | $18.86 | 2019 | |
| Assertio Therapeutics, INC. | $17.40 | 2020 | |
| Resmed Corp | $16.00 | 2019 | |
| Averitas Pharma INC. | $14.93 | 2024 | Qutenza |
| Ge Healthcare | $13.71 | 2019 | |
| Avion Pharmaceuticals | $13.67 | 2022 | |
| Impel Pharmaceuticals INC. | $13.28 | 2023 | Trudhesa |
| Vertical Pharmaceuticals, LLC | $11.46 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$345.36 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Schulman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.